PsyBio Therapeutics Corp. (PSYBF)
USD 0.0
(-98.0%)
USD 0.0
(-98.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | -50 Thousand USD | 20.0% |
| 2021 | -62.5 Thousand USD | 95.93% |
| 2020 | -1.53 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | -12.5 Thousand USD | 67.17% |
| 2023 Q2 | -25 Thousand USD | -100.0% |
| 2022 Q2 | -25 Thousand USD | -100.0% |
| 2022 Q4 | -38.07 Thousand USD | -204.61% |
| 2022 FY | -50 Thousand USD | 20.0% |
| 2022 Q1 | -12.5 Thousand USD | 51.39% |
| 2022 Q3 | -12.5 Thousand USD | 50.0% |
| 2021 FY | -62.5 Thousand USD | 95.93% |
| 2021 Q1 | -12.53 Thousand USD | 97.85% |
| 2021 Q2 | -12.38 Thousand USD | 1.25% |
| 2021 Q3 | -12.33 Thousand USD | 0.36% |
| 2021 Q4 | -25.71 Thousand USD | -108.43% |
| 2020 Q2 | -634.04 Thousand USD | 0.0% |
| 2020 FY | -1.53 Million USD | 0.0% |
| 2020 Q4 | -582.31 Thousand CAD | -119.95% |
| 2020 Q3 | -264.75 Thousand USD | 58.24% |
| 2020 Q1 | - USD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | -1950.021% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.427% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 84.351% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.042% |
| Qrons Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.806% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -3.608% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 59.759% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.333% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 1711.863% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.511% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 176.071% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -46.413% |
| Mesoblast Limited | -35.16 Million USD | 99.858% |
| Marizyme, Inc. | 457.7 Thousand USD | 110.924% |
| Genus plc | 178.7 Million USD | 100.028% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.023% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 180.352% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 112.19% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -354.545% |
| ContraFect Corporation | -154 Thousand USD | 67.532% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 165.137% |
| IMV Inc. | -962.29 Thousand USD | 94.804% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 87.097% |
| MultiCell Technologies, Inc. | 49.32 USD | 101478.751% |
| ONE Bio Corp. | 20.12 Million USD | 100.248% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.124% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 202.249% |
| Q BioMed Inc. | -8988.00 USD | -456.297% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.177% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -224.17% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.113% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 95.62% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 171.429% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -909.693% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 135.587% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 48.726% |
| GB Sciences, Inc. | -624.00 USD | -7912.821% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 41.879% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.001% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -23938.462% |
| Enzolytics Inc. | 30.7 Thousand USD | 262.824% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 110.364% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.005% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 90.282% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 108.099% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.012% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -464.589% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 40.369% |
| Kadimastem Ltd | -630.13 Thousand USD | 92.065% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 105.061% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 100.52% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.324% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -322.476% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 128.319% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 128.319% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 103.684% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -72.414% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 111.11% |
| SYBLEU INC | 11.69 Thousand USD | 527.497% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 101.085% |
| Bioxytran, Inc. | -8285.00 USD | -503.5% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 86.595% |
| Neutra Corp. | 14.33 Thousand USD | 448.797% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 39.024% |
| PureTech Health plc | -1.6 Million USD | 96.881% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 95.006% |
| IXICO plc | 3.27 Million USD | 101.529% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 92.795% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 97.208% |
| CSL Limited | 7.7 Billion USD | 100.001% |
| Cellectis S.A. | 18 Thousand USD | 377.778% |